-
Second Sight Medical Just Had Another Big Day...And More Headlines Could Be Coming
Tuesday, June 23, 2015 - 5:01pm | 436Second Sight Medical Products Inc (NASDAQ: EYES) shares were up sharply in early trading Tuesday after the company reported positive clinical trial results from a three-year multi center study post-implant of its Argus II Retinal Prosthesis System. The stock closed at $16.28, up 3.1 percent on...